As of 12:02pm ET
| +0.125 / +0.95%|
The 11 analysts offering 12-month price forecasts for ARIAD Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 22.00 and a low estimate of 7.00. The median estimate represents a -17.20% decrease from the last price of 13.29.
The current consensus among 11 polled investment analysts is to Buy stock in ARIAD Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.